TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.
作者:
主题词
青少年(Adolescent);成年人(Adult);儿童(Child);儿童, 学龄前(Child, Preschool);用药计划表(Drug Administration Schedule);女(雌)性(Female);基因表达(Gene Expression);移植物抗宿主病(Graft vs Host Disease);血液肿瘤(Hematologic Neoplasms);造血干细胞移植(Hematopoietic Stem Cell Transplantation);组织相容性试验(Histocompatibility Testing);人类(Humans);免疫球蛋白G(Immunoglobulin G);免疫抑制剂(Immunosuppressive Agents);男(雄)性(Male);中年人(Middle Aged);受体, 肿瘤坏死因子(Receptors, Tumor Necrosis Factor);受体, 肿瘤坏死因子, Ⅰ型(Receptors, Tumor Necrosis Factor, Type I);疾病严重程度指数(Severity of Illness Index);存活率分析(Survival Analysis);组织供者(Tissue Donors);移植预处理(Transplantation Conditioning);全身照射(Whole-Body Irradiation)
DOI
10.1016/j.bbmt.2012.03.013
PMID
22469883
发布时间
2021-10-21
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文